Goodwin Procter LLP has announced that a team of attorneysfrom Boston-based law firm Palmer & Dodge have joined the firm's Intellectual Property Litigation Practice in Boston.
Goodwin Procter's Intellectual Property Litigation Practice and the team from Palmer & Dodge have one large client in common, Teva Pharmaceuticals Inc., which is among the top 20 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.
"The addition of this top Palmer & Dodge team to Goodwin Procter will strengthen the firm's already formidable Intellectual Property Litigation Practice and offer Teva and our other IP clients an even deeper bench of support for their legal needs," said Regina M. Pisa, chairman and managing partner at Goodwin Procter.
Francis C. Lynch and Laurie S. Gill join Goodwin Procter as partners. Mr. Lynch focuses his practice on complex patent litigation and has represented major corporate clients in complex civil litigation for more than 25 years. Ms. Gill's practice focuses on intellectual property disputes, especially patent infringement and validity litigation, trademark and copyright infringement matters and cases involving trade secrets and non-competition covenants.
Goodwin Procter's patent and intellectual property litigation expertise has grown significantly over the last several years. Currently, the firm has more than 60 full time patent litigators, with a similar number of attorneys handling IP licensing and transactional work. With the Palmer & Dodge additions, the firm has eight science advisors and 17 staff members with Ph.D.s, primarily in the chemical, medical and electrical areas, to support litigation and opinion writing.